{"id":46251,"date":"2023-11-20T06:02:53","date_gmt":"2023-11-20T12:02:53","guid":{"rendered":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/aren0532-tumor-annotations-data\/"},"modified":"2024-04-01T11:20:04","modified_gmt":"2024-04-01T16:20:04","slug":"aren0532-tumor-annotations-data","status":"publish","type":"tcia_citation","link":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/aren0532-tumor-annotations-data\/","title":{"rendered":"AREN0532-TUMOR-ANNOTATIONS-DATA"},"template":"","class_list":["post-46251","tcia_citation","type-tcia_citation","status-publish"],"tcia_citation_type":"Data Citation","tcia_citation_text":"<p>Rozenfeld, M., &amp; Jordan, P. (2023). <strong>Annotations for Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, II, or III Wilms&#8217; Tumor (AREN0532-Tumor-Annotations) [Data set]<\/strong>. The Cancer Imaging Archive. <a href=\"https:\/\/doi.org\/10.7937\/KJA4-1Z76\">https:\/\/doi.org\/10.7937\/KJA4-1Z76<\/a><\/p>\n","tcia_citation_statement":"","tcia_citation_doi":"10.7937\/KJA4-1Z76","_links":{"self":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations\/46251","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations"}],"about":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/types\/tcia_citation"}],"wp:attachment":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/media?parent=46251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}